Electrical Signaling, Pain and Inflammation

Pain processing involves signals traveling through nerves, but pain is also shaped by context, tissue injury and central processing. Electrical stimulation devices differ in placement, waveform and intended use. They cannot be treated as one intervention simply because they all deliver current.

Separate pathways, separate evidence

Tracey's inflammatory-reflex review describes neural regulation of acute inflammation, including cholinergic signaling. It is not a chronic-pain device trial. Famm and colleagues outline neural-circuit electroceuticals as a discovery direction rather than reporting results for a particular pain device. A 2024 device review combined heterogeneous chronic non-cancer pain studies, including TENS combinations and PEMF for low-back pain; its authors called for larger, more diverse cohorts. The pooled results cannot establish benefit for every device or diagnosis.

What a responsive device would have to show

Sensor-guided stimulation is a design question: which signal corresponds to meaningful symptoms, how should exposure change, and does adaptation outperform a fixed protocol? Those questions require device- and condition-specific comparisons, tolerability assessment and patient-centered measures of function. None of the linked sources demonstrates that an Electrome system currently measures patient state or improves outcomes by adapting its output.

Steps for testing responsive pain stimulation Define a measurable signal and pain condition

Prespecify and test an adjustment rule

Compare function, pain and adverse events with fixed stimulation

What the linked references do not establish: The inflammatory-reflex and electroceutical papers and heterogeneous pain-device review do not establish efficacy for an adaptive platform.